Latest stories

RSV vaccines could offer protection against asthma

Ghent, November 28, 2025 – Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy infection with respiratory syncytial virus (RSV) significantly increases the risk of developing childhood asthma—especially in children with a family history of allergy or asthma. Their study, published today in Science Immunology, suggests that protecting newborns against RSV could substantially reduce asthma cases later in life.

New immune process identified that may alleviate Alzheimer's disease

Belgian collaboration drives new momentum in amyloidosis care and research 

World Amyloidosis Day – 26 October | First benefit concert supports new Fund 

Psoriasis-linked gene mutation also impacts gut health 

VIB researchers and colleagues uncover an unexpected role for psoriasis-associated gene CARD14 in intestinal function and disease. 

Belgian scientists discover how cells protect our skin from inflammatory disease – paving the way for new treatments

Researchers at VIB and Ghent University have uncovered a key mechanism that protects the skin from harmful inflammation

European scientists uncover new plant-based anti-inflammatory and anti-aging ingredients for sustainable cosmetics 

Confo Therapeutics – Unlocking the power of GPCRs

Same symptoms, different biology

Researchers uncover new insights into diverging disease mechanisms in ALS

New insights into melanoma plasticity uncover a critical role of iron metabolism

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-based Biotherapeutic Product Pipeline

Spica Therapeutics Secures €1 Million VLAIO Grant to Advance Groundbreaking Macrophage-Targeted Cancer Therapy